|Bid||63.47 x 1000|
|Ask||63.72 x 1000|
|Day's range||63.29 - 64.92|
|52-week range||53.22 - 69.75|
|Beta (5Y monthly)||0.63|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||2.16 (3.34%)|
|Ex-dividend date||06 Jan 2022|
|1y target est||N/A|
Bristol Myers Squibb (NYSE: BMY) has made some big acquisitions in the past, and it's now hinting that more deals could be on the way. The pharmaceutical giant recently announced a smaller licensing agreement with Century Therapeutics (NASDAQ: IPSC) instead of a big acquisition. In this Motley Fool Live video, recorded on Jan. 12, Fool contributors Keith Speights and Brian Orelli discuss what's behind Bristol Myers Squibb's latest partnership.
Bristol Myers Squibb (BMY) closed the most recent trading day at $63.54, moving -1.61% from the previous trading session.
Though crashes and corrections are inevitable, they're also an ideal opportunity to buy great stocks at a discount.